Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 52,910 |
|
|||||
| News | - | ||||||
| Day High | 3.13 | Low High |
|||||
| Day Low | 2.99 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ovid Therapeutics Inc | OVID | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.113 | 3.78% | 3.103 | 15:20:30 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.99 | 2.99 | 3.13 | 2.99 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 540 | 52,910 | $ 3.05 | $ 161,198 | - | 2.57 - 4.1389 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:20:42 | 33 | $ 3.11 | USD |
Ovid Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 219.2M | 70.71M | - | 392k | -52.34M | -0.74 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ovid Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OVID Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.19 | 3.29 | 2.99 | 3.15 | 143,681 | -0.087 | -2.73% |
| 1 Month | 3.08 | 3.35 | 2.99 | 3.16 | 137,935 | 0.023 | 0.75% |
| 3 Months | 3.81 | 4.10 | 2.60 | 3.15 | 211,065 | -0.707 | -18.56% |
| 6 Months | 3.50 | 4.10 | 2.57 | 3.25 | 173,421 | -0.397 | -11.34% |
| 1 Year | 3.04 | 4.1389 | 2.57 | 3.47 | 200,240 | 0.063 | 2.07% |
| 3 Years | 3.67 | 4.80 | 1.405 | 3.37 | 224,304 | -0.567 | -15.45% |
| 5 Years | 1.95 | 10.45 | 1.405 | 3.97 | 653,412 | 1.15 | 59.13% |
Ovid Therapeutics Description
| Ovid Therapeutics Inc is a biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering from epilepsies, seizure-related disorders, and neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life. |
